Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Happy hearts: Amgen's new drug may help people with cardiac failure to recover some heart function Michael Sohn/AP/Press Association Images

Company creating 100 Irish jobs has developed heart failure drug

Amgen – which is opening a new plant in Dun Laoghaire – announced late last week that an experimental drug may help cardiac patients’ hearts to recover function.

A BIOTECHNOLOGY COMPANY which is to create 100 jobs in Ireland is currently developing a drug which may help the recovery of people with heart failure.

On Friday, it was reported that the experimental drug Amgen has been developing with Cytokinetics in cases of patients with heart failure is showing signs that it can improve heart function. FireceBiotech.com noted that larger-scale trials have now begun on the drug, a protein that helps the heart to contract, but that early signs were encouraging.

If the drug proves effective over a sustained period of time, it could be available to patients within three or four years.

Amgen is to create 100 jobs in Dun Laoghaire, reports Gavin Daly in today’s Sunday Business Post. The American firm took over the former Pfizer plant in Dun Laoghaire last March, a move which saved 280 jobs there.

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Close
JournalTv
News in 60 seconds